Molecule,Therapy Area,Market Size (USD),Growth Rate (%),Competitors,Key Insights
Remdesivir,Antiviral,2.5B,15.3,Gilead Sciences,High demand during pandemics
Pembrolizumab,Oncology,15.8B,12.1,Merck,Leading immunotherapy drug
Insulin,Diabetes,25.4B,8.5,Novo Nordisk,Lifelong treatment market
Aspirin,Pain Relief,5.2B,2.1,Bayer,Generic competition intense
Statins,Cardiovascular,18.9B,5.4,Pfizer,Preventive medicine growth
Morphine,Pain Management,3.2B,4.2,Purdue Pharma,Controlled substance with regulatory challenges
Bivalirudin,Anticoagulant,1.8B,6.8,The Medicines Company,Direct thrombin inhibitor for PCI